147 related articles for article (PubMed ID: 18178226)
1. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance.
Moran LJ; Noakes M; Clifton PM; Norman RJ; Fenech MF
Mutat Res; 2008 Mar; 639(1-2):55-63. PubMed ID: 18178226
[TBL] [Abstract][Full Text] [Related]
2. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R
Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
[TBL] [Abstract][Full Text] [Related]
5. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
6. Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome.
Hamurcu Z; Bayram F; Kahriman G; Dönmez-Altuntas H; Baskol G
Gynecol Endocrinol; 2010 Aug; 26(8):590-5. PubMed ID: 20170347
[TBL] [Abstract][Full Text] [Related]
7. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
[TBL] [Abstract][Full Text] [Related]
8. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
9. Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome.
Yesilada E; Sahin I; Ozcan H; Yildirim IH; Yologlu S; Taskapan C
Eur J Endocrinol; 2006 Apr; 154(4):563-8. PubMed ID: 16556719
[TBL] [Abstract][Full Text] [Related]
10. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
11. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
12. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
14. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
15. High serum concentration of total inhibin in polycystic ovary syndrome.
Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal aberrations level in peripheral blood lymphocytes of women with polycystic ovary syndrome.
Nersesyan A; Martirosyan A; Parsadanyan G; Zalinyan G
J BUON; 2006; 11(4):477-80. PubMed ID: 17309180
[TBL] [Abstract][Full Text] [Related]
17. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D
Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122
[TBL] [Abstract][Full Text] [Related]
18. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
[TBL] [Abstract][Full Text] [Related]
19. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
Mancini F; Cianciosi A; Reggiani GM; Facchinetti F; Battaglia C; de Aloysio D
Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
[TBL] [Abstract][Full Text] [Related]
20. The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes.
Cho LW; Jayagopal V; Kilpatrick ES; Atkin SL
Ann Clin Biochem; 2009 May; 46(Pt 3):218-21. PubMed ID: 19389885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
